Lincoln Capital Corp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,585
Closed -$289K 83
2024
Q1
$289K Buy
1,585
+110
+7% +$20K 0.13% 58
2023
Q4
$229K Sell
1,475
-15
-1% -$2.33K 0.11% 69
2023
Q3
$222K Sell
1,490
-310
-17% -$46.2K 0.12% 67
2023
Q2
$243K Sell
1,800
-137
-7% -$18.5K 0.12% 63
2023
Q1
$309K Sell
1,937
-996
-34% -$159K 0.18% 49
2022
Q4
$474K Sell
2,933
-600
-17% -$97K 0.29% 41
2022
Q3
$474K Sell
3,533
-563
-14% -$75.5K 0.32% 41
2022
Q2
$627K Buy
4,096
+740
+22% +$113K 0.4% 40
2022
Q1
$544K Buy
3,356
+456
+16% +$73.9K 0.28% 44
2021
Q4
$393K Hold
2,900
0.19% 50
2021
Q3
$313K Hold
2,900
0.17% 48
2021
Q2
$327K Sell
2,900
-436
-13% -$49.2K 0.19% 43
2021
Q1
$361K Hold
3,336
0.23% 42
2020
Q4
$357K Hold
3,336
0.23% 40
2020
Q3
$292K Hold
3,336
0.21% 42
2020
Q2
$328K Buy
+3,336
New +$328K 0.26% 40
2020
Q1
Sell
-6,279
Closed -$556K 45
2019
Q4
$556K Sell
6,279
-895
-12% -$79.3K 0.41% 38
2019
Q3
$543K Sell
7,174
-168
-2% -$12.7K 0.46% 37
2019
Q2
$534K Sell
7,342
-703
-9% -$51.1K 0.47% 40
2019
Q1
$648K Sell
8,045
-2,008
-20% -$162K 0.59% 35
2018
Q4
$927K Sell
10,053
-463
-4% -$42.7K 0.85% 35
2018
Q3
$995K Sell
10,516
-22,703
-68% -$2.15M 0.83% 31
2018
Q2
$3.08M Sell
33,219
-1,490
-4% -$138K 2.86% 16
2018
Q1
$3.29M Sell
34,709
-11,074
-24% -$1.05M 3.05% 14
2017
Q4
$4.43M Sell
45,783
-3,578
-7% -$346K 3.78% 9
2017
Q3
$4.39M Sell
49,361
-966
-2% -$85.8K 3.92% 9
2017
Q2
$3.65M Buy
50,327
+475
+1% +$34.4K 3.23% 15
2017
Q1
$3.25M Sell
49,852
-5,251
-10% -$342K 2.9% 13
2016
Q4
$3.46M Buy
+55,103
New +$3.46M 3.33% 9